Rybelsus: A Breakthrough in Diabetes Management Rybelsus is a revolutionary medication approved for the treatment of type 2 diabetes. It belongs to a class of drugs known as GLP-1 receptor agonists, which help regulate blood sugar levels. Developed by Novo Nordisk, Rybelsus is the first oral GLP-1 receptor agonist available,[Read More…]